OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies
Mir Hilal Ahmad, M. Moshahid A. Rizvi, Mansoor Ali, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101840-101840
Closed Access | Times Cited: 51

Showing 26-50 of 51 citing articles:

The Effect of Crocin on Movement Disorders and Oxidative DNA Damage in Parkinson's Disease: Insights from a Randomized Controlled Trial
Saeed Mohammad Soleymani, Farhad Assarzadegan, Seyed Amir Hassan Habibi, et al.
Parkinsonism & Related Disorders (2024) Vol. 126, pp. 107051-107051
Closed Access | Times Cited: 1

The Aggregation of α-Synuclein in the Dorsomedial Striatum Significantly Impairs Cognitive Flexibility in Parkinson’s Disease Mice
Jing Chen, Yifang Liu, Mingyu Su, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1634-1634
Open Access | Times Cited: 1

Serum neurofilament light chain, markers of systemic inflammation and clinically relevant depressive symptoms in US adults
Menglu Guo, Changlin Zhu
Journal of Affective Disorders (2024) Vol. 363, pp. 572-578
Closed Access | Times Cited: 1

Non-Coding RNAs in Parkinson's Disease: Regulating SNCA and Alpha-Synuclein Aggregation
Lakshmi Thangavelu, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155511-155511
Closed Access | Times Cited: 1

The Anatomy and Clinical Significance of Sensory Disturbance in Parkinson's Disease
Benxu Ma, Jianying Zhang, Yanlei Cui, et al.
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 3
Open Access | Times Cited: 4

Downregulation of PACAP and the PAC1 Receptor in the Basal Ganglia, Substantia Nigra and Centrally Projecting Edinger–Westphal Nucleus in the Rotenone model of Parkinson’s Disease
Máté Fehér, Zsombor Márton, Ákos Szabó, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11843-11843
Open Access | Times Cited: 4

Possible Signaling Pathways in the Gut Microbiota–Brain Axis for the Development of Parkinson’s Disease Caused by Chronic Consumption of Food Additives
Melanie Verónica Martinez-Vega, Sebastián Galván-Menéndez-Conde, Verónica Freyre‐Fonseca
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 1950-1962
Closed Access | Times Cited: 2

Manganese activates autophagy and microglia M2 polarization against endoplasmic reticulum stress-induced neuroinflammation: Involvement of GSK-3β signaling
Yuqing Yang, Liang Gao, Jia Meng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116053-116053
Open Access | Times Cited: 2

MECANISMOS MOLECULARES DA DEGENERAÇÃO NEURONAL NA DOENÇA DE PARKINSON: UMA REVISÃO BIBLIOGRÁFICA
Ana Maria Santos Cardoso, Renata Azevedo Dutra Queiroz, Luana Elisa Lugli, et al.
RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 (2024) Vol. 5, Iss. 1, pp. e514810-e514810
Open Access

Parkinson's disease and Major depressive disorder: a bidirectional Mendelian randomization study
Yixuan Zhang
Neuroscience and Neurological Surgery (2024) Vol. 14, Iss. 03, pp. 01-05
Open Access

Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-induced mouse model of Parkinson’s disease
Begench Ovlyakulov, Beilei Hu, Hong-Yang Kan, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112715-112715
Closed Access

Progress of non‐motor symptoms in early‐onset Parkinson's disease
Fanshi Zhang, Ai‐Di Luo, Shusheng Liao, et al.
Ibrain (2024)
Open Access

P1 evoked by facial expression images is enhanced in Parkinson’s disease patients with depressive symptoms
Yujia Sun, Yixiang Mo, Chunkai Peng, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access

The Prevalence of Depressive Symptoms in Patients with Idiopathic Parkinson’s Disease: Cross-Sectional Study from Somalia
Mohamed Sheikh Hassan, Nur Adam Mohamed, Yücel Yavuz, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 5059-5068
Open Access

A utilização da terapia cognitiva comportamental no tratamento da depressão em pacientes com doença de Parkinson: uma revisão integrativa
Bianca Araújo Vieira, Alexandre Almeida da Silva, Júlio César Claudino dos Santos
Debates em Psiquiatria (2024) Vol. 14, pp. 1-17
Open Access

Serum neurotransmitter analysis of motor and non-motor symptoms in Parkinson’s patients
Yichun Fan, Wenping Yang, Weilan Wu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access

Cannabidiol induces autophagy via CB1 receptor and reduces α-synuclein cytosolic levels
Adolfo Garcia Erustes, Vanessa C. Abı́lio, Cláudia Bincoletto, et al.
Brain Research (2024), pp. 149414-149414
Open Access

HDAC6 Deficiency Has Moderate Effects on Behaviors and Parkinson’s Disease Pathology in Mice
Jiayin Zhao, Yongtao He, Yufei Duan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9975-9975
Open Access

Psychopharmacological treatment of depression and anxiety and their different drug delivery targets
Aditya Sharma, Md. Aftab Alam, Awaneet Kaur, et al.
Current Psychiatry Research and Reviews (2023) Vol. 20, Iss. 4, pp. 297-322
Closed Access

Structural network topology mediated cognitive impairment in Parkinson’s disease
Zhichun Chen, Guanglu Li, Liche Zhou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Scroll to top